Cardiac Patient Articles & Analysis
8 articles found
High-performance cardiopulmonary resuscitation (HP-CPR) is a technique that emphasizes delivering chest compressions at the correct depth and rate while avoiding excessive leaning and minimizing interruptions. Often referred to as high-quality CPR within the medical community, HP-CPR is a critical skill that anyone can learn to improve survival outcomes for sudden cardiac arrest (SCA) victims. ...
BACKGROUND: Recent studies have shown that patient-triggered cardiac event recorders (CER) have an increased diagnostic yield and are more cost effective than conventional 24-h-Holter electrocardiograms (ECGs) for the evaluation of sporadic, potentially arrhythmia-related symptoms. ...
ByNovacor
The study also revealed that using the CAM patch as a point of care solution in the emergency department resulted in new patient referrals to the cardiology/EP department. Between 2018 and 2020, 369 patients were discharged with the CAM patch from the emergency department, and 57 of those patients were then established as cardiac ...
Methods: Among fifty-two post-cardiac surgery patients, serum and urine Gal-3 levels were examined on intensive care unit (ICU) admission. In a rat renal I/R injury model, Gal-3 levels, renal function, and histopathology were evaluated in rats pretreated with P-MCP for one week (n = 16) compared to controls (n = 16). Results: Among ...
Introduction “Our priority is to provide our customers with the high purity water and steam that is critical to the development and manufacturing of life-saving medications now and for future generations.” —George Gsell, MECO President Nexus Pharmaceuticals, maker of difficult-to-manufacture, high quality, FDA-approved specialty and generic drugs, is opening a $250 million, ...
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). ...
Recapping TAILOR-PCI The TAILOR-PCI trial, funded by the Mayo Clinic and the National Institutes of Health (NIH), investigated whether rapid CYP2C19 genetic testing and personalized antiplatelet therapy could improve health outcomes for heart attack patients receiving cardiac stents. (1) This trial included 5,300 patients at 41 hospitals in the ...
Beijing, China (CNN)A major breakthrough in 3-D printed medicine could bring hope to nearly 1.8 billion patients with cardiovascular disease. Chinese scientists working for Sichuan Revotek have successfully 3-D printed blood vessels and implanted them in rhesus monkeys, the company said. ...